Aptevo Therapeutics Inc. (APVO) Operating income 2016–2025
Aptevo Therapeutics Inc. (APVO) annual operating income history from SEC filings — each fiscal year as reported.
-$26.3MFY2025 · since FY2016: -$138.8M → -$26.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.3M | -7.0% |
| FY2024 | -$24.6M | +14.8% |
| FY2023 | -$28.9M | -0.8% |
| FY2022 | -$28.6M | -33.8% |
| FY2021 | -$21.4M | +22.2% |
| FY2020 | -$27.5M | +32.9% |
| FY2019 | -$41.0M | +20.7% |
| FY2018 | -$51.7M | +4.2% |
| FY2017 | -$53.9M | +61.1% |
| FY2016 | -$138.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More APVO financial trends
APVO RevenueAPVO Net incomeAPVO Net marginAPVO Gross profitAPVO Gross marginAPVO Operating marginAPVO Operating cash flowAPVO Free cash flowAPVO Capital expendituresAPVO Return on equityAPVO Stock buybacksAPVO Dividends paidAPVO Total assetsAPVO Total liabilitiesAPVO Shareholders’ equityAPVO overview →